Skip to main content
TipRanks
Go Ultimate75% OFF

C'BON COSMETICS Co., Ltd. (4926) AI Stock Analysis

0 Followers
JP:4926

C'BON COSMETICS Co., Ltd.

(TSE/TYO:4926)

Select Model
Rating:76Outperform
Price Target:JPY 1,408.00â–²(12.91% Upside)
Action:reiterated
Date:11/18/26

C'BON COSMETICS earns a solid score primarily driven by its pristine, zero-debt balance sheet and a recent surge in free cash flow generation. Technical indicators show stable positive momentum as the stock trades above key moving averages. While valuation is reasonable with a moderate P/E, thin profit margins and historical inconsistency remain the primary risks to monitor.

Positive Factors
High Gross MarginsConsistently high gross margins indicate that C'BON retains substantial value from its skincare products and consultation-led sales model. This provides a durable buffer for operating costs and creates room to support services, customer relationships, and reinvestment even when revenue growth is modest.
Negative Factors
Thin Net ProfitabilityDespite strong gross margins, only a small portion of sales currently reaches the bottom line. The thin net margin and still-moderate return on equity leave limited room for cost increases or execution setbacks, making sustained earnings improvement important to the longer-term investment case.

C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)

-5%0%5%10%15%20%25%30%JP:4926+5.89%EWJ+11.03%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 5.18B
Dividend Yield
1.60%
Average Volume (3M)
1,096
Price to Earnings (P/E)
20.9
Beta (1Y)
0.18
Revenue Growth
1.51%
EPS Growth
-18.54%
Country
Japan
Employees
717
Sector
Consumer Defensive
Sector Strength
62
Industry
Household & Personal Products

C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model

Company Description

C'BON COSMETICS Co.,Ltd. is engaged in the development and distribution of a diverse range of beauty products, encompassing conventional cosmetics, quasi-pharmaceuticals, and aesthetic devices. Its comprehensive product line includes essentials such...

How the Company Makes Money

The company makes money primarily by selling cosmetics and skincare-related products directly to consumers, leveraging a counseling/face-to-face sales approach where beauty consultants recommend products based on a customer’s skin condition and needs...

C'BON COSMETICS Co., Ltd. Financial Statement Overview

Summary

C'BON COSMETICS demonstrates a strong financial turnaround, highlighted by a debt-free balance sheet and impressive cash flow generation. While top-line growth and gross margins are stable, a thin 2.3% net profit margin indicates vulnerability to cost fluctuations.

Income Statement

72Positive

Balance Sheet

88Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.28B9.27B8.84B8.50B8.53B9.15B
Gross Profit7.10B7.03B6.74B6.40B6.34B7.10B
EBITDA465.25M454.62M292.59M168.63M-92.22M329.61M
Net Income249.48M213.61M136.27M-26.35M-421.77M44.87M
Balance Sheet
Total Assets8.43B8.60B8.60B8.81B8.84B9.56B
Cash, Cash Equivalents and Short-Term Investments2.69B3.02B2.65B3.63B3.98B2.80B
Total Debt0596.00K04.24M13.27M22.30M
Total Liabilities2.64B2.91B2.89B3.15B3.13B3.36B
Stockholders Equity5.79B5.69B5.70B5.66B5.71B6.20B
Cash Flow
Free Cash Flow0553.88M-926.52M-301.11M-693.60M330.15M
Operating Cash Flow0763.10M-43.16M278.19M-81.47M433.37M
Investing Cash Flow0-159.99M-849.16M-581.94M1.35B44.91M
Financing Cash Flow0-240.69M-90.22M-31.20M-91.29M-6.73M

C'BON COSMETICS Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price1247.00

Price Trends

50DMA1238.65Positive
100DMA1233.89Positive
200DMA1241.63Positive

Market Momentum

MACD2.00Negative
RSI60.65Neutral
STOCH81.14Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Positive. The current price of 1247.00 is above the 20-day moving average (MA) of 1243.10, above the 50-day MA of 1238.65, and above the 200-day MA of 1241.63, indicating a bullish trend. The MACD of 2.00 indicates Negative momentum. The RSI at 60.65 is Neutral, neither overbought nor oversold. The STOCH value of 81.14 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4926.

C'BON COSMETICS Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

JP:4926 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4926JP:492676OutperformJPY 5.34B20.94―1.60%1.51%-18.54%
JP:4918JP:491869NeutralJPY 2.85B14.82―2.99%-5.54%-55.93%
JP:4925JP:492567NeutralJPY 6.25B10.83―2.42%-2.92%-25.96%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
JP:4934JP:493462NeutralJPY 4.52B12.24――-14.09%-22.72%
JP:4929JP:492956NeutralJPY 5.89B36.88―1.64%-1.71%314.83%
JP:4936JP:493644NeutralJPY 6.63B-13.33―3.64%-0.08%-246.12%

* Consumer Defensive Sector Average

Performance Comparison

-20%0%20%40%60%JP:4926JP:4918JP:4925JP:4929JP:4934JP:4936Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4926 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4926C'BON COSMETICS Co., Ltd.1247.0066.395.62%
JP:4918Ivy Cosmetics Corporation502.00187.0259.38%
JP:4925HABA Laboratories, Inc.1653.0011.310.69%
JP:4929ADJUVANT HOLDINGS CO., LTD.733.00-14.87-1.99%
JP:4934Premier Anti-Aging Co., Ltd.518.00-185.00-26.32%
JP:4936AXXZIA, Inc.275.00-129.94-32.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026